Literature DB >> 28386324

miRNA-21 promotes proliferation and invasion of triple-negative breast cancer cells through targeting PTEN.

Hong Fang1, Jiping Xie1, Min Zhang1, Ziwei Zhao1, Yi Wan1, Yongqiang Yao1.   

Abstract

MicroRNAs (miRNAs) are small single-stranded RNAs that bind to the 3'UTR of the mRNAs of target genes. They can target multiple genes and regulate translation or degradation of the mRNA. miRNAs target genes in a tissue-specific manner, and the role of a particular miRNA varies according to tumor origin or even subtype within the same cancer. This study evaluated the effect of miR-21 expression in triple-negative breast cancer (TNBC) tissues and MDA-MB-468, a cell line derived from TNBC tissues. miR-21 was consistently upregulated in TNBC and MDA-MB-468 cells compared to normal tissues. Inhibition of miR-21 by miR-21 antisense oligonucleotides decreased the proliferation, viability, and invasiveness of MDA-MB-468 cells and enhanced apoptosis. Furthermore, we confirmed that PTEN was downregulated by miR-21 in MDA-MB-468 cells. The results indicated that PTEN may mediate the oncogenic properties of miR-21 in TNBC. In summary, miR-21 was upregulated in TNBC tissues and cells, and promoted the proliferation and invasion of MDA-MB-468 cells, but negatively regulated the expression of PTEN protein. Inhibition of miR-21 or overexpression of PTEN protein could be promising strategies for the treatment of patients with TNBC.

Entities:  

Keywords:  PTEN; Triple-negative breast cancer; microRNA-21; migration; proliferation

Year:  2017        PMID: 28386324      PMCID: PMC5375989     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  24 in total

1.  Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.

Authors:  Arti B Gaur; Susan L Holbeck; Nancy H Colburn; Mark A Israel
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

2.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

3.  Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment.

Authors:  E Al Kahtani; Z Xu; S Al Rashaed; L Wu; A Mahale; J Tian; E B Abboud; N G Ghazi; I Kozak; V Gupta; J F Arevalo; E J Duh
Journal:  Eye (Lond)       Date:  2016-11-25       Impact factor: 3.775

4.  Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA.

Authors:  Jianjian Gao; Qingyun Zhang; Jianjun Xu; Lijuan Guo; Xuefeng Li
Journal:  Chin J Cancer Res       Date:  2013-12       Impact factor: 5.087

5.  miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.

Authors:  Hanqing Zhu; Chang Han; Dongdong Lu; Tong Wu
Journal:  Am J Pathol       Date:  2014-10       Impact factor: 4.307

6.  Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes.

Authors:  Hiroko Masuda; Keith A Baggerly; Ying Wang; Ya Zhang; Ana Maria Gonzalez-Angulo; Funda Meric-Bernstam; Vicente Valero; Brian D Lehmann; Jennifer A Pietenpol; Gabriel N Hortobagyi; W Fraser Symmans; Naoto T Ueno
Journal:  Clin Cancer Res       Date:  2013-08-15       Impact factor: 12.531

Review 7.  Regulation of miRNA strand selection: follow the leader?

Authors:  Hedda A Meijer; Ewan M Smith; Martin Bushell
Journal:  Biochem Soc Trans       Date:  2014-08       Impact factor: 5.407

8.  Identification of the conserved and novel miRNAs in Mulberry by high-throughput sequencing.

Authors:  Ling Jia; Dayan Zhang; Xiwu Qi; Bi Ma; Zhonghuia Xiang; Ningjia He
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

9.  Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration.

Authors:  S Jane Millward-Sadler; Patrick W Costello; Anthony J Freemont; Judith A Hoyland
Journal:  Arthritis Res Ther       Date:  2009-05-12       Impact factor: 5.156

10.  Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells.

Authors:  Yong Weon Yi; Wooyoung Hong; Hyo Jin Kang; Hee Jeong Kim; Wenjing Zhao; Antai Wang; Yeon-Sun Seong; Insoo Bae
Journal:  J Cell Mol Med       Date:  2013-04-20       Impact factor: 5.310

View more
  40 in total

1.  Effect of miR-146a-5p on proliferation and metastasis of triple-negative breast cancer via regulation of SOX5.

Authors:  Chengshuai Si; Qiao Yu; Yufeng Yao
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

Review 2.  Roles of miRNA and lncRNA in triple-negative breast cancer.

Authors:  Juan Xu; Kang-Jing Wu; Qiao-Jun Jia; Xian-Feng Ding
Journal:  J Zhejiang Univ Sci B       Date:  2020 Sept.       Impact factor: 3.066

3.  [Vitamin D down-regulates microRNA-21 expression to promote human placental trophoblast cell migration and invasion in vitro].

Authors:  Zhiyi Zhou; Xiaojuan Li; Guoqing Jiang; Jue Wang; Yuan Qian
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

4.  Increased miR-21a provides metabolic advantages through suppression of FBP1 expression in non-small cell lung cancer cells.

Authors:  Qingchun Dai; Na Li; Xiaohong Zhou
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

5.  Simultaneous delivery of anti-miRNA and docetaxel with supramolecular self-assembled "chitosome" for improving chemosensitivity of triple negative breast cancer cells.

Authors:  Xianfu Sun; Haipeng Xu; Tao Huang; Chengjuan Zhang; Junzhao Wu; Suxia Luo
Journal:  Drug Deliv Transl Res       Date:  2021-02       Impact factor: 4.617

6.  Curcumin suppresses gastric cancer biological activity by regulation of miRNA-21: an in vitro study.

Authors:  Weiwei Liu; Meixiang Huang; Qiuqiong Zou; Wanyi Lin
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

7.  miR-202 acts as a potential tumor suppressor in breast cancer.

Authors:  Shanshan Gao; Chunfang Cao; Qingfu Dai; Jian Chen; Jiancheng Tu
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

8.  Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.

Authors:  Olga A Patutina; Svetlana K Gaponova Miroshnichenko; Aleksandra V Sen'kova; Innokenty A Savin; Daniil V Gladkikh; Ekaterine A Burakova; Alesya A Fokina; Mikhail A Maslov; Elena V Shmendel'; Mattew J A Wood; Valentin V Vlassov; Sidney Altman; Dmitry A Stetsenko; Marina A Zenkova
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-07       Impact factor: 12.779

9.  Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients' survival by downregulating miR-21.

Authors:  Jianchao Gao; Sisi Wang; Zhisheng Zhang; Jun Li
Journal:  BMC Cancer       Date:  2021-06-28       Impact factor: 4.430

10.  LncRNA SENCR promotes cell proliferation and progression in non-small-cell lung cancer cells via sponging miR-1-3p.

Authors:  Ruirui Cheng; Guowei Zhang; Yong Bai; Furui Zhang; Guojun Zhang
Journal:  Cell Cycle       Date:  2021-07-05       Impact factor: 5.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.